Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ACC 2016: Novartis' Entresto reduces risk of hospitalization in HF patients
ACC 2016: Novartis' Entresto reduces risk of hospitalization in HF patients
ACC 2016: Novartis' Entresto reduces risk of hospitalization in HF patients
Submitted by
admin
on April 5, 2016 - 8:50am
Source:
BioPharma Dive
News Tags:
Novartis
Entresto
Headline:
ACC 2016: Novartis' Entresto reduces risk of hospitalization in HF patients
Do Not Allow Advertisers to Use My Personal information
